Home › Funds › EcoR1 Capital, LLC › RLAY

EcoR1 Capital, LLC position in RLAY

RELAY THERAPEUTICS INC COM · Health Care

EcoR1 Capital, LLC reported holding 697,948 shares of RLAY (RELAY THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$13.1M, representing 0.67% of its reported portfolio and ranking #18 among its reported holdings. EcoR1 Capital, LLC has disclosed RLAY holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)697.95K sh
Reported value held$13.06M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's RLAY position evolved

EcoR1 Capital, LLC first disclosed a stake in RLAY in Q3 2023 at 4,163,824 shares (US$35.0M). Across 6 filings, EcoR1 Capital, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 697,948 shares valued at US$13.1M — a reduction of -1,206,814 shares quarter over quarter.. Notable position changes include a 74% trim in Q4 2024 (shares fell 36% over the following quarter), a 63% trim in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.16M $35.02M New
Q3 2024 2.50M $17.70M New
Q4 2024 641.43K $2.64M Reduce
Q1 2025 641.43K $1.68M Hold
Q1 2026 1.90M $18.95M New
Q2 2026 697.95K $13.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has EcoR1 Capital, LLC held RLAY?

EcoR1 Capital, LLC has disclosed RLAY holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is EcoR1 Capital, LLC's current position in RLAY?

As of Q2 2026, EcoR1 Capital, LLC holds 697.95K shares of RLAY (RELAY THERAPEUTICS INC COM), valued at $13.06M, representing 0.67% of its reported portfolio and ranking #18.

Has EcoR1 Capital, LLC been buying or selling RLAY?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC reduced its position in RLAY.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.